|
HalfanDrug - Halfan The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Halofantrine Hydrochloride
Strength -
250MG
Applicant -
GLAXOSMITHKLINE
New Drug Application (NDA) Number -
020250
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Jul 24, 1992
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Glaxosmithkline
Halfan
Halobetasol Propionate 0.05% Ointment; Topical
Ultravate 0.05% Ointment; Topical Halfan 250mg Tablet; Oral Halobestasol Propionate 0.05% Cream; Topical Halobetasol Propionate 0.05% Cream; Topical Halobetasol Propionate 0.05% Cream; Topical Ultravate 0.05% Cream; Topical Halobetasol Propionate 0.05% Ointment; Topical Halobetasol Propionate 0.05% Ointment; Topical Halobetasol Propionate 0.05% Ointment; Topical NewDrugInformation |